Related Experiment Video
Updated: Jan 10, 2026

08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1.3K
Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.
Biorxiv : the Preprint Server for Biology
|November 24, 2025
Summary
Pathogenic SCN1A variants can cause epilepsy. Even variants at the same codon show diverse functional effects, impacting predictions of pathogenicity and disease severity.
Area of Science:
- Genetics and Molecular Biology
- Neuroscience
- Medical Genetics
Background:
- SCN1A gene variants are linked to epilepsy syndromes like Dravet syndrome and developmental and epileptic encephalopathy (DEE).
- Predicting the pathogenicity of SCN1A variants is challenging due to limited training data.
- Understanding variant function is crucial for correlating genotype with phenotype in epilepsy.
Purpose of the Study:
- To investigate the functional properties of four epilepsy-associated SCN1A variants affecting the same codon (I1347).
- To correlate observed channel dysfunction with clinical phenotypes in patients.
- To improve strategies for predicting SCN1A variant pathogenicity.
Main Methods:
- Whole-cell manual patch-clamp recordings were used to assess the function of heterologously-expressed NaV1.1 variants.
- Structural modeling utilizing AlphaFold 3 was performed to analyze protein structure.
- Clinical data from an individual with DEE and literature/ClinVar cases were analyzed.
Main Results:
- Four variants at codon I1347 (I1347T, I1347N, I1347V, I1347F) were studied in an individual with early infantile DEE and literature cases.
- Variants I1347T, I1347V, and I1347F exhibited mixed loss and gain-of-function properties.
- Variant I1347N demonstrated complete loss-of-function, with structural models indicating significant disruption of protein interactions.
Conclusions:
- SCN1A variants at the same codon can lead to divergent functional effects, impacting epilepsy phenotypes.
- Predicting the specific functional consequences of SCN1A variants should not solely rely on their position within the protein.
- These findings highlight the complexity of SCN1A-related epilepsies and the need for nuanced diagnostic approaches.
Related Concept Videos
Comparing Copy Number Variations and SNPs
18.5K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Mutations
94.3K
Overview
94.3K
RNA Splicing
60.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K

